Home > Boards > US Listed > Medical - Equipment > CHF Solutions, Inc (CHFS)

I filled Fri my first order. 513,000 O/S,

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
$oldier Hard Member Profile
Member Level 
Followed By 1,800
Posts 89,957
Boards Moderated 2
Alias Born 09/02/06
160x600 placeholder
Texas Health Resources Launches Ultrafiltration Therapy Using CHF Solutions’ Aquadex FlexFlow® System GlobeNewswire Inc. - 7/16/2019 8:30:00 AM
CHF Solutions To Exhibit At the American Association of Heart Failure Nurses 15th Annual Meeting GlobeNewswire Inc. - 6/25/2019 8:30:00 AM
CHF Solutions Sponsored AATS Session on Post-Cardiac Surgery, Highlighting Benefits of Using the Aquadex FlexFlow® System Fo... GlobeNewswire Inc. - 6/13/2019 8:30:00 AM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/31/2019 5:32:00 PM
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire Inc. - 5/29/2019 4:30:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 5:55:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 5:10:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 5:03:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 4:52:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 4:38:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/28/2019 4:15:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/24/2019 5:23:18 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/17/2019 9:19:20 AM
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare GlobeNewswire Inc. - 5/15/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 5:12:38 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 8:36:47 AM
CHF Solutions, Inc. Announces 17 Percent Increase in Revenues for First Quarter 2019 Over Previous Year and Provides Company ... GlobeNewswire Inc. - 5/7/2019 8:00:00 AM
CHF Solutions Welcomes Industry Veteran Nestor Jaramillo as Chief Commercial Officer GlobeNewswire Inc. - 5/6/2019 4:30:00 PM
CHF Solutions, Inc. To Announce First Quarter 2019 Financial Results on May 7, 2019 GlobeNewswire Inc. - 4/30/2019 8:30:00 AM
CHF Solutions to Sponsor CT Theatre Session, “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Managemen... GlobeNewswire Inc. - 4/23/2019 8:30:00 AM
CHF Solutions Announces Launch of Ultrafiltration Program at Heart Hospital at Saint Francis GlobeNewswire Inc. - 4/16/2019 8:30:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/9/2019 4:17:37 PM
CHF Solutions Announces Launch of Ultrafiltration Program at Oklahoma Heart Institute GlobeNewswire Inc. - 4/9/2019 8:30:00 AM
CHF Solutions Submits Patent Application for Pediatric Use of Aquadex FlexFlow® System GlobeNewswire Inc. - 4/3/2019 8:30:00 AM
CHF Solutions to Exhibit at The International Society for Heart and Lung Transplantation 2019 Annual Meeting and Scientific S... GlobeNewswire Inc. - 3/28/2019 8:30:00 AM
$oldier Hard Member Level  Sunday, 02/24/19 09:33:19 PM
Re: Johnny O post# 1282
Post # of 1293 
I filled Fri my first order. 513,000 O/S, 5.5 mil cash, 0 debt.

CHF Solutions, Inc. Announces 80% Revenue Growth for its Fourth Quarter and Provides Company Update

EDEN PRAIRIE, Minn., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter and year ended December 31, 2018, which included the following highlights:

Revenue for the fourth quarter ended December 31, 2018 increased 80.4 percent compared to the same period in 2017. Revenue growth for the year 2018 was 40.7 percent compared to the year 2017.
Continued marketing focus into post-cardiovascular surgery and heart failure outpatient clinics.
Commenced discussions with the FDA to request a label modification to include pediatrics.
Continued international expansion with announcement of new distributor agreements in India and Brazil.
Announced the filing of two new patent applications to deepen the company’s intellectual property protection of its Aquadex Flexflow® system.
Ended the quarter with $5.5 million in cash and cash equivalents and no debt.

“Our fourth quarter and year-end performance reflects the significant work our team accomplished during 2018. We achieved impressive revenue growth and continued to make strides in our commercialization efforts,” said John Erb, chairman and CEO of CHF Solutions. “I look forward to executing on the additional market opportunities we have identified, which we believe will deliver additional growth in 2019 and beyond.”

The Company will host a conference call and webcast at 9:00 AM ET today to discuss its financial results and provide an update on the Company’s performance. To access the live webcast, please visit http://ir.chf-solutions.com/events. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 4589101. An audio archive of the webcast will be available following the call at http://ir.chf-solutions.com/events.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist